Company news

Easton Pharmaceuticals Inc (OTC:EAPH) news

Easton Pharmaceuticals Inc news releases on 6ix. Latest, Dec 1, 2014: Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing…

View Easton Pharmaceuticals Inc →

Press releases — page 3

Easton Pharmaceuticals Finalizes and Forwards Its 2013 Audited Financials to an Existing Medical Marihuana Acquisition Target and a Health Canada Medical Marijuana for Medical Purposes (MMPR) Applicant

December 1, 2014

Ecigmarkets.com Black Friday / Cyber Week Sale and MMPR Update

November 26, 2014

Easton Launches www.EcigMarkets.com Ahead of Schedule and Commences Distributorship of Snoop Dog's Product Lines

October 31, 2014

Easton Finalizes and Launches Vaporizer Initiatives and Responds to Shareholder Questions

October 23, 2014

Easton Pharmaceuticals Secures Financing Commitment Towards Closing of Its Option on Canadian Medical Marijuana Facility and Business

October 13, 2014

Easton Pharmaceuticals Letter to Shareholders

October 7, 2014

Easton Pharmaceuticals Provides AMFIL Update on the mPact - GROzone Antimicrobial System

September 23, 2014

Easton Pharmaceuticals Announces Preparations for North American Product(s) Launch

September 15, 2014

Easton Pharmaceuticals Announces Financing Update; Provides Additional Due Diligence Documents to Canadian Based Brokerage Firm Towards Financing

August 22, 2014

Easton Pharmaceuticals Announces Medical Marijuana Site Facility Visit and Inspection

August 11, 2014

Easton Pharmaceuticals Announces the Completion and Shipping of the mPact -GROzone Antimicrobial System; Provides Other Updates

August 6, 2014

Easton Pharmaceuticals Provides Update on mPACT-Grozone 60(TM) and Other Corporate Initiatives

July 16, 2014

Easton Pharmaceuticals Announces Legal Action Against Seeking Alpha Writer as a Response to Libelous Article

July 8, 2014

Easton Pharmaceuticals Inc. Announces Medical Marijuana Facility Buildout Nears Completion as per MMPR Health Canada Guidelines Prior to Inspection Towards Obtaining MMJ Growers License

July 1, 2014

Easton Pharmaceuticals Finalizing Investment Terms in Private Medical Marijuana Device Company; Moves to Initiate Legal Action Against Libelous Seeking Alpha Article

June 25, 2014

Easton Pharmaceuticals Announces 2 Medical Marijuana Investment Proposals Which Include the Launch of Medical Marijuana Dispensary(s) in the State of Michigan and an Investment Into Medical Marijuana Technologies to Assist Growers With Harvests

June 6, 2014

Easton Pharmaceuticals Announces New Non-Dilutional Financing Source to Be Utilized Towards Its Medical Marijuana Initiative and Acquisitions

June 4, 2014

Easton Pharmaceuticals Announces the Closing of Medical Marijuana Agreement With MDRM Group (Canada) Ltd., on Purchasing an Ownership Interest in a Growers License in Canada's Federal Medical Marijuana Industry

June 2, 2014

Easton Pharmaceuticals Receives Final Changes and Nears Completion on Its Reg. A SEC Filing to Raise Up to $5,000,000 in Additional Committed Financing

April 23, 2014

Easton Pharmaceuticals Signs "Viorra" Distribution Deal for Mexico

April 14, 2014

Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program

April 3, 2014

Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board

March 31, 2014

Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives

March 28, 2014

Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development

March 25, 2014

Easton Pharmaceuticals Announces It Has Engaged Online Marketing and Branding Specialists to Support the Firm's Updated Products, Branding and Website Launch; Provides Update on Its Medical Marijuana Initiatives

March 19, 2014

Global Links' Hemp Life Today Division Enters Agreement With Easton Pharmaceuticals to Create Hemp-Based Product Line

March 11, 2014

Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis Innovative Pharmaceuticals, Signs Additional LOI and Partnership Agreement Towards Medical Marijuana Acquisition(s), Places Funds in Escrow Towards a Final Agreement and Closing

March 3, 2014

Easton Pharmaceuticals Announces the Launching of Hempstral SA, a New Hemp Based Anti Ageing Product & Reaches Marketing Develop and Distribution Agreement With HempLifeToday.com

February 27, 2014

Easton Pharmaceuticals to Attend and Introduce Its New & Existing Product Line at the Total Health Show

February 20, 2014

Easton Pharmaceuticals Is in Receipt of Proposal to Increase Current Financing; Provides Other Initiative Updates

February 10, 2014

Easton Pharmaceuticals Signs Letter of Intent / NDA, Enters Into Negotiations With Private B.C. Company Who Has Received Federal License Approval on Medical Marijuana & Closes on Agreement to Engage Leading Legal Consultant

February 7, 2014

Easton Pharmaceuticals Announces Update to VIORRA Initiative: Manufacturing Set to Begin

February 3, 2014

Easton Pharmaceuticals Moves Towards Formerly Engaging Leading Legal Expert on Medical Marijuana Licence, as Well as Moving to Next Level of Medical Marijuana Negotiations With Request for Term-Sheet and Final Due Diligence Documents

January 29, 2014

Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives

January 16, 2014

Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra"

December 11, 2013

Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising

November 6, 2013

Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA

November 4, 2013

Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014

October 22, 2013

Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives

October 4, 2013

← Newer